The stock price of Alnylam Pharmaceuticals, a relatively smaller pharmaceutical company with a market capitalization of $18 billion, has seen a 22% rise over the last twenty-one trading days, and we believe the stock will likely continue to rally in the near term. The 22% rise can primarily be…
What’s Next For Alnylam Stock After The Recent 22% Rise?
2021-06-11T13:30:00-04:00June 11th, 2021|
Related Posts
-
DJT Stock Is Bouncing Back. Here’s Why., Go to article
May 2nd, 2024